Healthcare Industry News: Silicon Nitride
News Release - October 31, 2007
Amedica Receives FDA 510(k) Clearance for Valeo(TM) Cervical PlateSALT LAKE CITY, Oct. 31 (HSMN NewsFeed) -- Amedica Corporation, an orthopedic implants company focused on Silicon Nitride ceramic technologies, announced today that the U.S. Food and Drug Administration has granted 510(k) marketing clearance to Amedica's Valeo(TM) Cervical Plate system.
"We are extremely pleased to receive FDA clearance of the Valeo CP system," said Ashok Khandkar, Ph.D., Chief Executive Officer of Amedica Corporation. "The clearance of this implant represents another milestone toward the commercialization of our innovative suite of spinal products."
Amedica Corporation is an emerging orthopedic implant company focused on using its Silicon Nitride ceramic technologies to develop and commercialize a broad range of innovative, high-performance spine and joint implants for the growing orthopedic device market. Its products under development include spine, reconstructive hip and knee implants that may represent a new standard of care in total joint implants based on superior durability, performance and safety.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.